Activities of RNMOT |
III All-Russian student olympiad on therapy in Nizhny Novgorod
|
|
Guideline for practitioners |
L.P. Sokolova, I.V. Knyazev, Ye.A. Sukhareva
Mental capacity disorders under stress and their correction
|
|
REVIEWS |
V.V. Cheltsov, A.I. Martynov, Yu.Sh. Gushchina, T.S. Illarionova, E.A. Korovyakova
Metabolic therapy in chronic heart failure
|
|
A.L. Khokhlov, Yu.V. Rybachkova
Antagonists of mineralocorticoid receptors in myocardial infarction: focus on eplerenone
|
|
N.A. Karoli, A.P. Rebrov
Some aspects of pathogenesis and prevention of sudden cardiac death in patients with chronic obstructive pulmonary disease
|
|
V.V. Cheltsov, Yu.Sh. Gushina, T.S. Illarioniva, E.А. Korovyakova, A.E. Moiseeva, A.P. Pereversev, Ye.Yu. Stefanenko, S.K. Ziryanov
Angiotensin II receptor blockers: focus on cardesartan
|
|
Ye.N. Dudinskaya, O.N. Tkacheva
Prospects for the use of moxonidine (Physiotens®) in the prevention of bone resorption and aging of the vascular wall
|
|
JUBILEE |
For the 65th anniversary of Arkady L. Vertkin
|
|
MAIN ISSUE |
T.Yu. Demidova, V.V. Salukhov
Empagliflozin: a new era in the treatment of diabetes mellitus type 2
|
|
T.A. Meleshkevich, Ye.I. Luchina, M.Ye. Shevchenko
Diabetic polyneuropathy. Briefly about the main
|
|
T.Yu. Demidova, M.V. Stelmakh
Modern facilities and future prospects in pharmacotherapy of obesity
|
|
T.P. Kiseleva, A.Yu. Sokolova
Clinical aspects of suppressive therapy with levothyroxine (brief literature review)
|
|
I.V. Druk, Ye.A. Ryapolova
Metformin: updated guidance and pleiotropic potential
|
|
T.Yu. Demidova, I.N. Drozdova
Influence of fenofibrate on dyslipidemia and diabetic polyneuropathy in patients with diabetes mellitus type 2
|
|
Yu.V. Zaviyalova, N.N. Borovkov, O.V. Zanozina, N.Yu. Borovkova
Peculiarities of arterial hypertension in patients with acromegaly in active phase
|
|
T.Yu. Demidova
Sulfonylurea derivatives in the light of evidence-based medicine and algorithms of diabetes mellitus type 2
|
|